Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes

This paper describes the effects of a switch to velaglucerase alfa in a group of adult patients with type 1 Gaucher disease, all of whom had previously had their dose reduced as a consequence of the worldwide imiglucerase shortage. Thirty-two patients from two large European Gaucher centers switched...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: van Dussen, Laura, Cox, Timothy M., Hendriks, Erik J., Morris, Elizabeth, Akkerman, Erik M., Maas, Mario, Groener, Johanna E. M., Aerts, Johannes M.F.G., Deegan, Patrick B., Hollak, Carla E. M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ferrata Storti Foundation 2012
Aiheet:
Original Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590092/
https://ncbi.nlm.nih.gov/pubmed/22773601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.059071
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia